ライフサイエンスコーパス: ventilatory support

1 ergoing tracheostomy and receiving prolonged ventilatory support.

2 atients were monitored during 64 episodes of ventilatory support.

3 ure infants who require prolonged periods of ventilatory support.

4 us that can assist with decisions to provide ventilatory support.

5 expiratory muscle pacing to provide complete ventilatory support.

6 creasing the risk for failed liberation from ventilatory support.

7 ustained a WOBTot of 0.6 to 1 J/L during the ventilatory support.

8 , broad-spectrum antibiotics, and mechanical ventilatory support.

9 blood products, fluid balance, and modes of ventilatory support.

10 c, may alleviate the anxiety associated with ventilatory support.

11 spiratory failure to insure need for ongoing ventilatory support.

12 ostomy to patients with a need for continued ventilatory support.

13 maintaining diaphragm activity under partial ventilatory support.

14 nsion, cautious diuresis, and, if necessary, ventilatory support.

15 volume and gas exchange while requiring less ventilatory support.

16 eased level of consciousness often requiring ventilatory support.

17 childhood, but survived to adulthood without ventilatory support.

18 h-75th percentile) of 9.0 (5.0-14.0) days of ventilatory support.

19 unit hospitalization, or days on mechanical ventilatory support.

20 nsplant and subsequently required mechanical ventilatory support.

21 intensive care unit who required mechanical ventilatory support.

22 l responses to sternal closure or changes in ventilatory support.

23 minor respiratory interventions, and use of ventilatory support.

24 ssfully extubated without needing additional ventilatory support.

25 ed from normotensive donors after 6 hours of ventilatory support.

26 EPA+GLA required significantly fewer days of ventilatory support (11 vs. 16.3 days; p = .011), and ha

27 The preset proportion of ventilatory support (30%, 50%, and 70%) unloaded the wor

28 (age, 59 +/- 17 yrs; duration of mechanical ventilatory support, 45 +/- 36 days [mean +/- sd]) agree

29 right-heart catheterisation (57 vs 22%); and ventilatory support (54 vs 38%).

30 ithholding cardiopulmonary resuscitation and ventilatory support after day 3 of coma.

31 f > or =34 wks who were receiving mechanical ventilatory support and had echocardiographic and clinic

32 jective measurement to guide the adequacy of ventilatory support and interpret apparent clinical wean

33 ge in oxygenation and duration of mechanical ventilatory support and supplemental oxygen therapy.

34 extubation, despite the need for continuous ventilatory support and, thereby, decrease the need to r

35 l-cause death, respiratory failure requiring ventilatory support, and hospitalization duration.

36 Organ Failure Assessment score, duration of ventilatory support, and mortality.

37 n supplementation, nasogastric-tube feeding, ventilatory support, and relative improvement in the cli

38 Two patients were discharged with nocturnal ventilatory support, and the rest were completely weaned

39 sive care unit, number of days on mechanical ventilatory support, and time to death.

40 us TGI at two levels of decreased mechanical ventilatory support; and (2) determine an appropriate ti

41 ry rehabilitation, self-management, and home ventilatory support are becoming increasingly important,

42 o had advanced respiratory failure requiring ventilatory support at the time of oseltamivir initiatio

43 hors attempted to re-engineer the process of ventilatory support based on measured work of breathing

44 ostomy should be made on day 8 of mechanical ventilatory support because of the low probability of su

45 rials resulted in liberation from mechanical ventilatory support before another spontaneous breathing

46 he rest were completely weaned of mechanical ventilatory support before discharge.

47 birth weight of 1250 g or less who required ventilatory support between 7 and 21 days of age.

48 Ventilatory support, blood-pressure reduction, intracran

49 ble clinical accuracy for patients receiving ventilatory support by using an ANN.

50 Pneumonia rates per 1000 ventilatory support days were 20:1000 in the HHME-24 gro

51 yr of age) were disconnected from mechanical ventilatory support during Stage III-IV NREM, and their

52 ed through an oral endotracheal tube (off of ventilatory support) during 1 min of spontaneous respira

53 For patients requiring ventilatory support for > or = 20 days, 100% of patients

54 riterion is likely to prolong intubation and ventilatory support for a large number of patients.

55 ne for hypotension, and one patient required ventilatory support for hypoxia.

56 Adult patients with ventilatory support for more than 60 days.

57 of ACS, leading to endotracheal intubation, ventilatory support for respiratory failure, and erythro

58 Among ICU patients receiving acute ventilatory support for respiratory failure, PDM resulte

59 mmendations about withholding or withdrawing ventilatory support for respiratory failure.

60 ht (OR, 3.41; 95% CI, 1.61-7.26), and use of ventilatory support for the newborn (OR, 2.85; 95% CI, 1

61 Ventilatory support for the patient was successfully man

62 ions of domiciliary medical technology, home ventilatory support has either led or run in parallel wi

63 after extubation and timely reinstitution of ventilatory support has the potential to reduce the incr

64 AV-ECMO may provide efficient ventilatory support in the neonatal population with hype

65 % of infants vs. 48.7%, P=0.04), less use of ventilatory support (in 4.0% vs. 10.8%, P=0.01), and few

66 tions, group B RSV infection rarely required ventilatory support, in contrast to group A infections (

67 maternal benzodiazepine treatment, rates of ventilatory support increased by 61 of 1000 neonates and

68 asive hemodynamic monitoring, and aggressive ventilatory support, inhaled nitric oxide was administer

69 ome measures assessed included inotropic and ventilatory support, intensive care, and hospital stay.

70 theterisation, intravenous inotropic agents, ventilatory support, intra-aortic balloon counterpulsati

71 rms of mechanical support include mechanical ventilatory support, intraaortic balloon counterpulsatio

72 Ventilatory support is appropriate for some transplant c

73 spiratory distress should be considered when ventilatory support is not readily available.

74 iated with mortality included precannulation ventilatory support longer than 2 wks and lower precannu

75 atients) or 3 days (reintubated patients) of ventilatory support met tracheostomy criteria.

76 sed long before enteral feeding or assistive ventilatory support might be considered.

77 associated with an increase in intensity of ventilatory support, NIV failure, and intensive care uni

78 Nonstandard ventilatory support of patients with CDH has led to sign

79 ffect of prone positioning during mechanical ventilatory support on outcomes.

80 ed to continuous use of noninvasive IPPV for ventilatory support on room air.

81 been discharged from the hospital, need for ventilatory support or an intracranial catheter, and a P

82 has no substantial impact on the duration of ventilatory support or mortality.

83 dexamethasone or placebo with either routine ventilatory support or permissive hypercapnia.

84 2.06; 95% CI, 1.87-2.27; p<.0001), prolonged ventilatory support (OR, 1.79; 95% CI, 1.72-1.86; p<.000

85 zes the trends and growing evidence base for ventilatory support outside the hospital.

86 m 19 were successfully weaned off mechanical ventilatory support over a mean period of 3.7+/-4.0 days

87 One of the great advances in ventilatory support over the past few decades has been t

88 Ventilatory support parameters and systemic PaO2/FiO2 ra

89 Outcome measures included ventilatory support parameters, arterial blood gases, or

90 =.046), but not with duration of mechanical ventilatory support (r = -.23) or VRU admission Acute Ph

91 Length of mechanical ventilatory support ranged from 1 to 112 days, mean 14.8

92 and 36% of the patients required mechanical ventilatory support, ranging in duration from 1 to 70 da

93 s with unplanned extubation occurring during ventilatory support required reintubation.

94 preextubation measures of breathing effort, ventilatory support, respiratory mechanics, central insp

95 urs), broad-spectrum antibiotic therapy, and ventilatory support resulted in full recovery without th

96 If patients failed due to hypoxia, ventilatory support resumed.

97 c therapist whenever desired while receiving ventilatory support, self-initiated use of noise-canceli

98 mised after delayed sternal closure and that ventilatory support should be increased to counteract th

99 wise, the minute volume of positive pressure ventilatory support should be limited with potential sev

100 t such effect may provide future noninvasive ventilatory support strategies in patients with CCHS and

101 resent at various times during the period of ventilatory support, supporting a role for mediator-indu

102 ciated with a shorter duration of mechanical ventilatory support than was early parenteral nutrition

103 underlying disease, rather than duration of ventilatory support, that have a significant impact on Q

104 e care unit admission, the need for invasive ventilatory support, the length of hospital stay, or the

105 cipients who subsequently require mechanical ventilatory support, there appear to be some groups with

106 Titrating ventilatory support to maintain normal levels of inspira

107 if they met eligibility criteria for partial ventilatory support, tolerated pressure support ventilat

108 ay in small infants unable to be weaned from ventilatory support, tracheobronchography may be a more

109 nd with an increased frequency of oxygen and ventilatory support use.

110 evious myocardial infarction, renal disease, ventilatory support, use of circulatory support, glycopr

111 , comorbidities, hemodynamic parameters, and ventilatory support used before ECLS.

112 In survivors of prolonged mechanical ventilatory support, using specific selection criteria s

113 Ventilatory support variables, airway care, device costs

114 Nitric oxide was discontinued when ventilatory support was decreased to a PEEP of < or = 6

115 to predict which patients required extended ventilatory support was limited.

116 Ventilatory support was measured by the fraction of insp

117 oxygen therapy, nasogastric-tube feeding, or ventilatory support was recorded.

118 Prolonged mechanical ventilatory support was the most common indication.

119 h confirmed H1N1 pneumonia and on mechanical ventilatory support were randomized to receive adjuvant

120 Arterial blood gases and level of ventilatory support were recorded before and at 6, 24, 4

121 Supplemental oxygen and ventilatory support were required in 67.9% and 11.1%, re

122 ency requiring airway support or oxygenation/ventilatory support were treated with bilevel positive a

123 tment could not be blinded, vasopressors and ventilatory support were weaned by protocol.

124 Higher PCO2 levels may allow a reduction in ventilatory support which reduces the risk of lung injur

125 This condition necessitates ventilatory support, which when prolonged leads to acute

126 s lung-protective ventilation during partial ventilatory support, while maintaining diaphragm activit

127 Survivors of prolonged mechanical ventilatory support who were discharged from a ventilato

128 oxygen (Pao2) decreases to 40 mm Hg, despite ventilatory support with a fraction of inspired oxygen (

129 respiratory flutter and permitted weaning of ventilatory support within a few hours.

130 days alive and breathing without mechanical ventilatory support within the first 28 days after rando